BioSpace News Archive

Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genomically defined cancers, announced the appointment of Scott Garland to the Company’s board of directors.

Recro Pharma, Inc. announced that company management will host a webcast to discuss the company’s recently announced acquisition of IRISYS, a San Diego-based CDMO that possesses capabilities that complement and expand those of Recro.

Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, reported its unaudited financial results for the second quarter of the year and recent business highlights.

BeiGene and EUSA Pharma Announce China NMPA Approval of QARZIBA ® (Dinutuximab Beta) for Patients with High-Risk Neuroblastoma

StageZero Life Sciences, a specialist in PCR testing dedicated to the early detection of multiple disease states through whole blood, announced its second-quarter financial results for the three months ended June 30, 2021, and provided an update on its business progress.

BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will host a key opinion leader (KOL) webinar on its Deep TMS™ therapy for treating mental health disorders on Tuesday, August 31, 2021, at 11am Eastern Time.

AnPac Bio-Medical Science Co., Ltd. today announces that it has hired Dr. Sunil Pandit, a successful life sciences veteran and highly accomplished bio-medical scientist, as its U.S. CEO, effective Aug. 16, 2021.

Humacyte, Inc today announced advancements in its commercial operations with the appointment of B.J. Scheessele as Chief Commercial Officer.

Lyra Therapeutics, Inc. will host Chronic Rhinosinusitis (CRS) Key Opinion Leader Event on Tuesday, August 31, 2021 from 3:00 p.m. - 4:30 p.m. ET.

Braxia Scientific Corp. is pleased to announce its management’s participation at the upcoming H.C. Wainwright 23rd Annual Global Investment Conference.